Aspiriant LLC Portfolio holdings
Top Buys
| 1 |
iShares National Muni Bond ETF
MUB
|
+$111M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$100M |
| 3 |
Vanguard Global ex-US Real Estate ETF
VNQI
|
+$30M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$27.2M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$24.7M |
Top Sells
| 1 |
State Street SPDR Dow Jones International Real Estate ETF
RWX
|
+$44.8M |
| 2 |
iShares US Real Estate ETF
IYR
|
+$9.86M |
| 3 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
+$9.04M |
| 4 |
iShares Core S&P US Value ETF
IUSV
|
+$6.89M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$6M |
Sector Composition
| 1 | Financials | 5.06% |
| 2 | Healthcare | 1.94% |
| 3 | Technology | 1.9% |
| 4 | Industrials | 1.45% |
| 5 | Consumer Staples | 1.42% |
Similar funds
Aspiriant LLC's Q4 2016 Portfolio in Review
As of Q4 2016, Aspiriant LLC held 192 positions worth $1.1B, up 9.9% from $1B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Aspiriant LLC deployed $310M of net new capital in Q4 2016, opening 10 new positions and adding to 70 existing holdings. Its largest new stake was Meta Platforms (Facebook): 12,760 shares worth $1.47M.
By sector, the portfolio is most concentrated in Financials at 5.1% of assets, down from 5.5% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR Dow Jones International Real Estate ETF, an estimated $44.8M trimmed.
- Aspiriant LLC's largest Q4 2016 buy was Meta Platforms (Facebook): 12,760 shares worth $1.47M.
- Aspiriant LLC added most to iShares National Muni Bond ETF in Q4 2016, an estimated $111M increase.
- Aspiriant LLC's biggest Q4 2016 reduction was State Street SPDR Dow Jones International Real Estate ETF, cutting an estimated $44.8M.
- Aspiriant LLC fully exited WisdomTree Europe Hedged Equity Fund in Q4 2016, selling an estimated $1.98M.
- Aspiriant LLC's ten largest holdings make up 54% of its $1.1B portfolio in Q4 2016.
- Aspiriant LLC opened 10 new positions and closed 9 in Q4 2016.
- Aspiriant LLC's portfolio value rose 9.9% quarter-over-quarter to $1.1B.
Based on Aspiriant LLC's 13F filing for Q4 2016, filed 10 Feb 2017.